Trijardy XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0597-0390 -
Package NDC
0597-0390-13 -
Package NDC
0597-0390-71 -
Application number
NDA212614 -
SPL ID
40d8f12b-47be-4a48-be56-9cd025ac63d4 -
SPL set ID
71873567-9594-452a-bb92-34a129adecac -
UNII
3X29ZEJ4R2 -
UNII
HDC1R2M35U -
UNII
786Z46389E -
RxCUI
2359279 -
RxCUI
2359285 -
RxCUI
2359288 -
RxCUI
2359290 -
RxCUI
2359351 -
RxCUI
2359353 -
RxCUI
2359356 -
RxCUI
2359358
What the source publishes
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Active ingredients
- empagliflozin, linagliptin, metformin hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Trijardy XR
- empagliflozin, linagliptin, metformin hydrochloride
- EMPAGLIFLOZIN
- LINAGLIPTIN
- METFORMIN HYDROCHLORIDE
Complete source data
{
"name": "Trijardy XR",
"splId": "40d8f12b-47be-4a48-be56-9cd025ac63d4",
"labels": [
{
"setId": "71873567-9594-452a-bb92-34a129adecac",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71873567-9594-452a-bb92-34a129adecac",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71873567-9594-452a-bb92-34a129adecac"
}
],
"routes": [
"ORAL"
],
"labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)",
"package_ndc": "0597-0390-13",
"identifierStatus": "well-formed",
"marketing_start_date": "20200423"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)",
"package_ndc": "0597-0390-71",
"identifierStatus": "well-formed",
"marketing_start_date": "20200423"
}
],
"productId": "0597-0390_40d8f12b-47be-4a48-be56-9cd025ac63d4",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "0597-0390",
"deaSchedule": null,
"genericName": "empagliflozin, linagliptin, metformin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EMPAGLIFLOZIN",
"strength": "25 mg/1"
},
{
"name": "LINAGLIPTIN",
"strength": "5 mg/1"
},
{
"name": "METFORMIN HYDROCHLORIDE",
"strength": "1000 mg/1"
}
],
"applicationNumber": "NDA212614",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200423",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175912",
"N0000175913",
"N0000187059",
"N0000187058"
],
"unii": [
"3X29ZEJ4R2",
"HDC1R2M35U",
"786Z46389E"
],
"rxcui": [
"2359279",
"2359285",
"2359288",
"2359290",
"2359351",
"2359353",
"2359356",
"2359358"
],
"spl_set_id": [
"71873567-9594-452a-bb92-34a129adecac"
],
"pharm_class_epc": [
"Dipeptidyl Peptidase 4 Inhibitor [EPC]",
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Dipeptidyl Peptidase 4 Inhibitors [MoA]",
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Boehringer Ingelheim Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0597-0390_40d8f12b-47be-4a48-be56-9cd025ac63d4"